Design Therapeutics Inc

Research Design Therapeutics Inc (DSGN) on Bullrun: market cap USD 889.39M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerDSGN
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 889.39M
• Financial periodFY2025
• Net income-USD 69.79M
• Free cash flow-USD 54.55M

Valuation Snapshot

latest market cap is USD 889.39M.

About Design Therapeutics Inc

Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States. The company utilizes its GeneTAC platform to design and develop therapeutic candidates for inherited diseases caused by nucleotide repeat expansion.

Frequently asked questions

What is Design Therapeutics Inc's market cap?

Design Therapeutics Inc's market capitalization is USD 889.39M.

What does Design Therapeutics Inc do?

Design Therapeutics, Inc. a clinical-stage biopharmaceutical company, research, designs, develops, and commercializes small molecule therapeutic drugs for the treatment of genetic diseases in the United States.